Dolby Laboratories, Inc. insider sold shares
- Sold 6,831 shares at $58.72
- Sold 836 shares at $59.33
- Purchased 7,667 shares at $45.50
John D Couling
DLB
Dolby Laboratories, Inc. SEC filings
Every EDGAR filing for Dolby Laboratories, Inc. (DLB), newest first, with AI summaries and stories.
- Ticker
- DLB
- CIK
- 1308547
- Latest filing
- Oct 5
Next: earnings expected ~Nov 16 · 10-K expected ~Nov 17 (deadline Nov 24)
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 planned 10b5-1 sales ($451K), 1 grant or exercise.
Filings
4Dolby Laboratories, Inc.DLBLIVE 4Dolby Laboratories, Inc.DLBLIVE Dolby Laboratories, Inc. reports trust transfers
- Dagmar Dolby Trust transferred 24,108,162 Class B shares on 10/02/2026
- Multiple trusts hold shares with voting power shared with David E. Dolby
- Transfers were for tax and estate planning, no value exchanged
Dagmar Dolby · DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED · +1 more
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling
4Dolby Laboratories, Inc.DLBLIVE 3 insider filings
Marc Whitten, insider filing for DLB
Show all 3
- 4Insider filing for DLB
- 4Insider filing for DLB
- 4Insider filing for DLB
Marc Whitten, reporting
S-8Dolby Laboratories, Inc.DLBLIVE 4Dolby Laboratories, Inc.DLBLIVE John D Couling, insider filing for DLB
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
4Dolby Laboratories, Inc.DLBLIVE 2 insider filings
Dagmar Dolby, insider filing for DLB
Show all 2
- 4Insider filing for DLB
- 3New insider at DLB
Dagmar Dolby, reporting · DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999, reporting
4Dolby Laboratories, Inc.DLBLIVE Ryan Nicholson, insider filing for DLB
Ryan Nicholson, reporting
8-KDolby Laboratories, Inc.DLBLIVE 144Dolby Laboratories, Inc.DLBLIVE Ryan Nicholson, planned sale of DLB shares
Ryan Nicholson, reporting
4Dolby Laboratories, Inc.DLBLIVE Shriram Revankar, insider filing for DLB
Shriram Revankar, reporting
144Dolby Laboratories, Inc.DLBLIVE Shriram Revankar, planned sale of DLB shares
Shriram Revankar, reporting
4Dolby Laboratories, Inc.DLBLIVE Ryan Nicholson, insider filing for DLB
Ryan Nicholson, reporting
144Dolby Laboratories, Inc.DLBLIVE Ryan Nicholson, planned sale of DLB shares
Ryan Nicholson, reporting
4Dolby Laboratories, Inc.DLBLIVE Ryan Nicholson, insider filing for DLB
Ryan Nicholson, reporting
4Dolby Laboratories, Inc.DLBLIVE John D Couling, insider filing for DLB
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
10-QDolby Laboratories, Inc.DLBLIVE 8-KDolby Laboratories, Inc.DLBLIVE 4Dolby Laboratories, Inc.DLBLIVE John D Couling, insider filing for DLB
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
SCHEDULE 13G/ADolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
4Dolby Laboratories, Inc.DLBLIVE John D Couling, insider filing for DLB
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
SDDolby Laboratories, Inc.DLBLIVE 4Dolby Laboratories, Inc.DLBLIVE Todd Pendleton, insider filing for DLB
Todd Pendleton, reporting
144Dolby Laboratories, Inc.DLBLIVE Todd Pendleton, planned sale of DLB shares
Todd Pendleton, reporting
4Dolby Laboratories, Inc.DLBLIVE Shriram Revankar, insider filing for DLB
Shriram Revankar, reporting
144Dolby Laboratories, Inc.DLBLIVE Shriram Revankar, planned sale of DLB shares
Shriram Revankar, reporting
4Dolby Laboratories, Inc.DLBLIVE Robert J Park, insider filing for DLB
Robert J Park, reporting
144Dolby Laboratories, Inc.DLBLIVE Robert J Park, planned sale of DLB shares
Robert J Park, reporting
SCHEDULE 13G/ADolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
4Dolby Laboratories, Inc.DLBLIVE John D Couling, insider filing for DLB
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
144Dolby Laboratories, Inc.DLBLIVE John D Couling, planned sale of DLB shares
John D Couling, reporting
10-QDolby Laboratories, Inc.DLBLIVE 8-KDolby Laboratories, Inc.DLBLIVE SCHEDULE 13GDolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
SCHEDULE 13GDolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
SCHEDULE 13G/ADolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by Bank of New York Mellon Corp (amended)
Bank of New York Mellon Corp, filed by
4Dolby Laboratories, Inc.DLBLIVE Emily Rollins, insider filing for DLB
Emily Rollins, reporting
144Dolby Laboratories, Inc.DLBLIVE Emily Rollins, planned sale of DLB shares
Emily Rollins, reporting
SCHEDULE 13G/ADolby Laboratories, Inc.DLBLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
4Dolby Laboratories, Inc.DLBLIVE Dagmar Dolby, insider filing for DLB
Dagmar Dolby, reporting · DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999, reporting
4Dolby Laboratories, Inc.DLBLIVE 2 insider filings
Shriram Revankar, insider filing for DLB
Show all 2
- 4Insider filing for DLB
- 4Insider filing for DLB
Shriram Revankar, reporting